Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart BioLineRx Ltd.

Equities

BLRX

IL0011015182

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:53 2024-05-28 am EDT 		5-day change 1st Jan Change
17.7 ILa +2.91% Intraday chart for BioLineRx Ltd. +11.32% -53.66%
02:30pm Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
May. 24 BioLineRx Ltd. Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer at American Society of Clinical Oncology CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BIOLINERX LTD.
Bio Therapeutic Drugs
+2.91%+11.32%-53.66%-52.55%-86.73% 56.09M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. Charts BioLineRx Ltd.
  5. Comparison Chart